中文版
  • Company news


Ansun BioPharma Closes $85 Million Series A Financing

May 14, 2018

Ansun Biopharma, based in San Diego, closed on a Series A financing round worth $85 million. The round was led by Sinopharm Healthcare Fund and Lilly Asia Ventures. New investors included Oceanpine Capital, Lyfe Capital, Yuanming Capital, Matrix Partners

Dave Chenn, CEO of Oceanpine Capital attended the BFA Annual Conference 2018

Apr 27, 2018

The Boao Forum for Asia (BFA) Conference, a high- level forum for leaders from governments, Bsinesses and academia in Asia and other continents runs from April

Dave Chenn, CEO of Oceanpine Capital was honored as one of the " Top Ten Figures in CED 2017"

Apr 19, 2018

Dave Chenn, CEO of Oceanpine Capital was honored as one of the " Top Ten Figures in China for Economic Development for 2017"
123